The prevalence of occult N2/3 NSCLC in tumours with a central location, size larger than 3cm or N1 disease on imaging: a single-centre retrospective study.

F. Liew (London, United Kingdom), K. Groom (London, United Kingdom), A. Shearer (London, United Kingdom), C. Ross (London, United Kingdom), R. Sinharay (London, United Kingdom)

Source: Virtual Congress 2020 – Screening and early lung cancer
Session: Screening and early lung cancer
Session type: E-poster session
Number: 1616
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Liew (London, United Kingdom), K. Groom (London, United Kingdom), A. Shearer (London, United Kingdom), C. Ross (London, United Kingdom), R. Sinharay (London, United Kingdom). The prevalence of occult N2/3 NSCLC in tumours with a central location, size larger than 3cm or N1 disease on imaging: a single-centre retrospective study.. 1616

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The efficacy and safety of induction chemoradiotherapy (ICRT) followed by surgery in stage III NSCLC patients (pts) with T3/4-adjacent organ invasion involved(AOI): A single-center retrospective observational study.
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018



Relevance of clinical TNM-staging in small cell lung cancer (SCLC) for survival – A retrospective case study in 633 patients
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010


Presence of concurrent sarcoid-like granulomas indicates better survival in cancer patients: a retrospective cohort study
Source: ERJ Open Res, 6 (4) 00061-2020; 10.1183/23120541.00061-2020
Year: 2020



An observational study of incident diagnoses of children’s diffuse parenchymal lung disease (ChILDEU)
Source: International Congress 2018 – Primary ciliary dyskinesia and lung function tests in respiratory morbidities
Year: 2018


The causes and consequences for dose reduction in NSCLC IIIB patients, a retrospective single center clinical trial.
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021


Evaluation of gene mutation status and metastasis in lung adenocarcinoma: a multicentric prospective study in Turkey
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019

The diagnostic value of integrated PET/CT in solitary pulmonary nodules in an area with the world‘s highest recorded incidence of tuberculosis (a pilot study)
Source: Annual Congress 2010 - State of the art imaging
Year: 2010


Clinical strategy in patients with multiple synchronous suspect lung lesions. A reflection on the current TNM classification based on 54 cases with complete follow-up
Source: Eur Respir J 2001; 18: Suppl. 33, 478s
Year: 2001

EBUS-TBNA for the diagnosis of centrally located primary lung lesions: a retrospective series
Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology
Year: 2008


Videothoracoscopic lung biopsy (VATS-LB) in the diagnosis of diffuse interstitial lung disease (DILD) and evaluation of an outpatient surgical approach. A prospective multicentric study
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008


Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer: a prospective multicentre study
Source: Eur Respir J, 50 (6) 1701493; 10.1183/13993003.01493-2017
Year: 2017



A retrospective study of the cause and impact of delayed diagnosis of lung cancer (LC)
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008

TNM and survival in small cell lung cancer: results of a population-based study
Source: Eur Respir J 2001; 18: Suppl. 33, 394s
Year: 2001

A preliminary comprehensive hormonal evaluation on a prospective group of patients (pts) with advanced lung cancer
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009

The role of radial endobronchial ultrasound for peripheral lung cancer tissue sampling and prognostic biomarkers analysis – a single-center retrospective study
Source: International Congress 2019 – Interventional pulmonology: endobronchial ultrasound-transbronchial needle aspiration
Year: 2019


A multicenter phase II study of docetaxel (D) weekly in advanced non-small cell lung cancer (NSCLC) in elderly and/or poor performance status (PS) patients (pts): preliminary results of the 0202 GFPC study
Source: Annual Congress 2005 - Chemotherapy and palliative care
Year: 2005


Preliminary analysis of a multicenter phase III trial comparing docetaxel (D) versus docetaxel/cisplatin (DC) in patients with inoperable advanced and metastatic non small cell lung cancer (NSCLC)
Source: Annual Congress 2003 - Advanced lung cancer treatment
Year: 2003


Unsuspected N2 disease: A retrospective analysis comparing survival in patients with suspected N2 disease in non-small cell lung cancer
Source: International Congress 2017 – Thoracic surgery
Year: 2017

Screening for incidence of lung cancer (LC) among the patients with pulmonary pathology (with special reference to histological subtype and TNM-staging system) in Ukraine
Source: Eur Respir J 2005; 26: Suppl. 49, 537s
Year: 2005

Long time survival after resection for multiple primary lung cancers. A population-based study
Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology
Year: 2005